SUCAMPO PHARMACEUTICALS, INC. Deferred Revenue
SUCAMPO PHARMACEUTICALS, INC. had Deferred Revenue of $2.12 million as of 2016-12-31, per its 10-K filed 2017-03-08.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2017-03-08
- 2016-12-31: Deferred Revenue $2.12M.
- 2015-12-31: Deferred Revenue $1.76M.
- 2015-09-30: Deferred Revenue $4.18M.
- 2014-12-31: Deferred Revenue $7.17M.
| Period end | Deferred Revenue |
|---|---|
| 2016-12-31 | $2.12M 10-K · filed 2017-03-08 |
| 2015-12-31 | $1.76M 10-K · filed 2017-03-08 |
| 2015-09-30 | $4.18M 10-Q · filed 2015-11-04 |
| 2014-12-31 | $7.17M 10-K/A · filed 2016-03-16 |
| 2013-12-31 | $7.53M 10-K · filed 2015-03-09 |
| 2012-12-31 | $10.79M 10-K · filed 2014-03-12 |